Here are relevant reports on : anti-virus-software-market-report
-
Pharmaceutical Microfiltration Market by type (Membrane filter, Depth filter, Virus filter, Air Filter, Assemblies), Sterility Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030
The global pharmaceutical microfiltration market, valued at US$5.66 billion in 2024, stood at US$6.13 billion in 2025 and is projected to advance at a resilient CAGR of 10.1% from 2025 to 2030, culminating in a forecasted valuation of US$9.94 billion by the end of the period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Zika Virus Testing Market by Technology, (Molecular Test (Polymerase Chain Reaction, Nucleic Acid Amplification Testing), Serology Test (Elisa, Prnt), End User (Diagnostic Laboratory, Hospital, Clinics, Academic Institutes) - Global Forecast to 2023
The Zika virus is a mosquito-borne flavivirus that was initially discovered in Uganda’s Zika forest in 1947. Before 2015, outbreaks of Zika virus infection had been restricted to some parts of Africa, Asia, and the South Pacific. In early 2015, a widespread outbreak of Zika fever, caused by the Zika virus detected in Brazil and subsequently spread to other parts of South and North America. Due to this, a number of countries issued travel warnings, and the outbreak will result in restricts tourism significantly. Furthermore, the outbreak raised concerns regarding the safety of athletes and viewers at the 2016 Summer Olympics in Rio de Janeiro. This sudden outbreaks resulted in increased demand for Zika virus testing.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Filtration Market by Product (Membrane filter, Depth filter, Virus filter, Air Filter, Assemblies, Systems (Single-use)), Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Global Forecast to 2030
The global pharmaceutical filtration market, valued at US$13.41 billion in 2024, stood at US$14.35 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2024 to 2030, culminating in a forecasted valuation of US$21.75 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
North America Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Assemblies, Systems (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030
The North America pharmaceutical filtration market, valued at USD 5.18 billion in 2024, stood at USD 5.56 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2024 to 2030, culminating in a forecasted valuation of USD 8.54 billion by the end of the period. The North America pharmaceutical filtration market is experiencing rapid growth. This expansion is primarily due to the implementation of stricter quality standards, the increasing demand for sterile drug manufacturing, and the rising use of biologic therapies.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Filtration Consumables Market by Type (Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies), Technique (Ultrafiltration), Sterility Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030
The pharmaceutical filtration consumables market, valued at US$11.19 billion in 2024, stood at US$11.96 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$18.03 billion by the end of the period. The pharmaceutical filtration consumables market is expanding rapidly, driven by factors such as the shift toward single-use technologies (SUTs) and disposables and advancements in membrane filter designs.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029
The global biologics safety testing market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$7.2 billion by the end of the period. Growth of the market can be attributed to factors such as the rising need for novel biotherapeutics and increasing focus on advancement of biopharmaceutical industry.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Agricultural Microbials Market by Function (Soil Amendment and Crop Protection), Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables), Type (Bacteria, Fungi, Virus, Protozoa), Application, and Region - Global Forecast to 2030
The market for agricultural microbials is projected to reach USD 18.75 billion by 2030, register a CAGR of 14.7% during the forecast period. The report profiles key players such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group (Switzerland), UPL (India), Corteva (US), FMC Corporation (US), Nufarm (Australia), Sumitomo Chemical Co., Ltd. (Japan), BIONEMA (US), Koppert (Netherlands), Certis USA L.L.C. (US), Bioceres Crop Solutions (Argentina), Novonesis Group (Denmark), BioFirst Group (Belgium), and Lallemand Inc (Canada).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Respiratory Syncytial Virus (RSV) Vaccines Market by Technology (Recombinant, Inactivated & Subunit, Others), Type (Monovalent, Multivalent), End User (Pediatric, Adult) & Region – Global Forecast to 2030
The global Respiratory Syncytial Virus (RSV) Vaccines market, valued at US$1.53 billion in 2024, stood at US$1.60 billion in 2025 and is projected to advance at a resilient CAGR of -4.9% from 2025 to 2030, culminating in a forecasted valuation of US$1.24 billion by the end of the period. Growth is driven by the high burden of RSV among infants and older adults.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies, System (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User-Forecast to 2030
The Asia Pacific pharmaceutical filtration market, valued at USD 3.24 billion in 2024, stood at USD 3.50 billion in 2025 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2030, culminating in a forecasted valuation of USD 5.58 billion by the end of the period. The Asia Pacific pharmaceutical filtration market is experiencing growth, driven by quality regulations, rising demand for sterile drug production, and the increasing adoption of biologic therapies.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
